Kumiai Chemical Industry Co., Ltd. Revises H1 Earnings Forecast — Net Profit Nearly Doubles
Kumiai Chemical Industry Co., Ltd. (TSE:4996) raised its interim earnings guidance for the fiscal year ending October 2026, citing strong agrochemical sales and accelerated shipments ahead of generic competition.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 92.8bn | JPY 102.9bn | +10.9% |
| Operating Profit | JPY 6.10bn | JPY 10.4bn | +70.5% |
| Ordinary Income | JPY 8.20bn | JPY 13.7bn | +67.1% |
| Net Profit | JPY 4.40bn | JPY 8.70bn | +97.7% |
| EPS | JPY 36.54/share | JPY 72.24/share | +97.7% |
The company attributed the upward revision to accelerated sales of Axsieve, its flagship agrochemical product, as management front-loaded shipments before generic competition enters the U.S. market. Additionally, the specialty chemicals division delivered stronger-than-expected sales. Despite planned charges for impairment losses and restructuring expenses, the company expects substantial profit growth in the interim period.
However, the company maintained its full-year earnings forecast unchanged, signaling caution over geopolitical headwinds. Management cited escalating Middle East tensions and prolonged regional conflict as downside risks to full-year performance. The interim upside reflects timing benefits rather than sustained demand acceleration, suggesting investors should monitor full-year guidance closely for any further adjustments as geopolitical conditions evolve.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.